Skip to main content

Table 4 Evaluation of participant’s engagement with the study

From: Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan

Contents

N

%

All participants

220

–

Questioner (conducted after answering cTTO and VAS)

 Q1, ‘I found it easy to imagine the scenarios I was asked’

  Strongly agree

101

45.9%

  Agree

110

50.0%

  Disagree

8

3.6%

  Strongly disagree

1

0.5%

 Q2, ‘I found it easy to tell the difference between the lives I was asked to think about’

  Strongly agree

147

66.8%

  Agree

71

32.3%

  Disagree

2

0.9%

  Strongly disagree

0

0.0%

 Q3, ‘I found it difficult to decide on my answers to the questions’

  Strongly agree

57

25.9%

  Agree

117

53.2%

  Disagree

44

20.0%

  Strongly disagree

2

0.9%

Analysis population

201

–

 Participants evaluated utility value of PD > SD

1

0.5%

 Time per cTTO task in seconds, median (IQR)

94 (74–125)

 Times of Trade-offs in cTTO, mean (SD)

5.28 (1.96)

cTTO tasks

1827

–

 Utility score = −1

90

4.9%

 Utility score = 0

238

13.0%

 Utility score = 1

3

0.2%

  1. cTTO Composite time trade off, VAS Visual analog scale, PD Progressive disease, SD Stable disease, IQR Interquartile range